Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

ICICI Prudential Nifty Pharma ETF · Regular ✕Mirae Asset BSE Midcap 150 Momentum 30 ETF · Regular ✕

Growth of ₹10,000

Basics

ICICI Prudential Nifty Pharma ETFMirae Asset BSE Midcap 150 Momentum 30 ETF
CategoryEquity ETFsEquity ETFs
PlanRegularRegular
Fund houseICICI PruMirae Asset
NAV₹28.3748₹12.8008
NAV date20 Nov 202619 Nov 2026
History1 months4 months
Expense ratio5.7%1.4%
StarsNot ratedNot rated
Growth Score——

Returns

ICICI Prudential Nifty Pharma ETFMirae Asset BSE Midcap 150 Momentum 30 ETF
1 month+10.14%+4.92%
3 months—−1.10%
6 months——
YTD——
1 year——
3 years (CAGR)——
5 years (CAGR)——
10 years (CAGR)——
Since launch+10.14%+2.26%

Risk

ICICI Prudential Nifty Pharma ETFMirae Asset BSE Midcap 150 Momentum 30 ETF
Volatility——
Downside volatility——
Sharpe——
Sortino——
Calmar——
Return / risk——
Deepest fall−2.74%−12.90%
Days to recover——
Below its high−1.75%−3.67%

Against benchmark

ICICI Prudential Nifty Pharma ETFMirae Asset BSE Midcap 150 Momentum 30 ETF
Alpha——
Beta——
R²——
Up capture——
Down capture——
Tracking error——
Information ratio——
Treynor——

Consistency

ICICI Prudential Nifty Pharma ETFMirae Asset BSE Midcap 150 Momentum 30 ETF
Best 1-year——
Middle 1-year——
Worst 1-year——
1-year periods with a loss——
Middle 3-year——
Positive months——
Best day—+1.84%
Worst day—−3.08%
Worst 5% day—−1.85%
Positive days—54.1%
NAVs a year—86

SIP of ₹10,000 a month

ICICI Prudential Nifty Pharma ETFMirae Asset BSE Midcap 150 Momentum 30 ETF
5-year XIRR——
5-year value——
3-year XIRR——
1-year XIRR——

Holdings overlap i

Overlap needs the monthly portfolio filing of at least two of these funds; not loaded yet.

Search Growth